• Genoa in the News

Chain Drug Review features Genoa Healthcare’s efforts to increase vaccine access for medically underserved populations

Aug 15th, 2022

When the COVID-19 vaccine became widely available last year, Genoa Healthcare® pharmacists administered immunizations to thousands of consumers across the country and demonstrated the critical role pharmacists have in providing life-saving preventive care for medically underserved populations. Genoa’s ongoing effort to continue reaching these communities and ensure they have access to immunizations was recently featured in Chain Drug Review.

“The populations who are the most at risk of serious illness from viruses are often the same populations that experience significant barriers in receiving immunizations to prevent infection,” said Christy Barr, Genoa’s senior vice president of pharmacy operations. “Our pharmacy teams will do whatever we can to make sure the communities we serve have access to receive their flu vaccine this year.” You can read the full article in Chain Drug Review’s recent issue.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Partnering with Genoa
CMS reporting now required: 4 ways Genoa can help

By Reena Neumann, PharmD, MBA Since January 1, 2024, the Centers for Medicare & Medicaid Services (CMS) has required that clinics provide outcomes data reporting to secure federal funding through...

  • Consumer Stories
  • People-first Pharmacy Care
For people in crisis, access to a safe place is critical

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...

  • Consumer Stories
  • People-first Pharmacy Care
Genoa pharmacist saves the life of someone she’s never met

Having witnessed the effects of the opioid crisis in her community firsthand, Genoa Healthcare® Pharmacist Kristen Pyland had prepared for the day she’d need to rush into action to aid...

Partner with Genoa
  • Behavioral Health
  • Clinical Insights
  • Treatment
Brixadi®: 3 things to know about the buprenorphine treatment option

Staying on top of new medication therapy options for your consumers living with opioid use disorder (OUD) can be difficult. Learn how the new FDA-approved medication, Brixadi®, can help support...